The group's principal activity is to provide nutritional adjunct to the medical treatment for chronic immuno-compromising debilitating diseases like acquired immune deficiency syndrome, hepatitis and cancer. The group is a research based bio-nutraceutical corporation in the field of nutritional science. The group developed two novel enteral nutritional formulas resurgex(R) and resurgex plus(tm), which plays an important role as a nutritional adjunct to the medical treatment for certain chronic immuno-compromising debilitating diseases. The resurgex(R) and resurgex plus(tm) have been formulated to address the loss of lean muscle, nutrient depletion, immune support, mitochondrial dysfunction and oxidative stress in individuals, undergoing medical treatment for chronic immuno-compromised medical conditions.
